Article Versions Notes

Christopher BN, Golick L, Basar A, Reyes L, Robinson RM, Angerstein AO, Krieg C, Hobbs GA, Guttridge DC, O’Bryan JP, et al. Modulating the CXCR2 Signaling Axis Using Engineered Chemokine Fusion Proteins to Disrupt Myeloid Cell Infiltration in Pancreatic Cancer. Biomolecules. 2025; 15(5):645. https://doi.org/10.3390/biom15050645

Christopher, Benjamin N., Lena Golick, Ashton Basar, Leticia Reyes, Reeder M. Robinson, Aaron O. Angerstein, Carsten Krieg, G. Aaron Hobbs, Denis C. Guttridge, John P. O’Bryan, and et al. 2025. "Modulating the CXCR2 Signaling Axis Using Engineered Chemokine Fusion Proteins to Disrupt Myeloid Cell Infiltration in Pancreatic Cancer" Biomolecules 15, no. 5: 645. https://doi.org/10.3390/biom15050645

Christopher, B. N., Golick, L., Basar, A., Reyes, L., Robinson, R. M., Angerstein, A. O., Krieg, C., Hobbs, G. A., Guttridge, D. C., O’Bryan, J. P., & Dolloff, N. G. (2025). Modulating the CXCR2 Signaling Axis Using Engineered Chemokine Fusion Proteins to Disrupt Myeloid Cell Infiltration in Pancreatic Cancer. Biomolecules, 15(5), 645. https://doi.org/10.3390/biom15050645